Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01186380 · ClinicalTrials.gov registry record

Safety of the PET-512MC Transesophageal Transducer

A clinical trial, sponsored by Toshiba America Medical Systems.

Completed
Registry status
50
Enrollment target

NCT01186380: Completed study, sponsored by Toshiba America Medical Systems.

NCT01186380 is a clinical trial that has completed, run by Toshiba America Medical Systems. The registered enrollment target is 50 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01186380 has completed, sponsored by Toshiba America Medical Systems.

COMPLETED
Registry status
50 participants
Enrollment target

Study Summary

The objective of this Study is to demonstrate the safety of the PET-512MC TEE transducer as it is inserted and transitioned into the esophagus through the mouth.

Interventions

  • DEVICE PET-512MC

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2010-08
Est. Completion 2010-11
Toshiba America Medical Systems

3 total trials

What the finished NCT01186380 record still lists

NCT01186380 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.

The record links to 0 conditions, and to 1 intervention - of which PET-512MC is the first listed.

NCT01186380 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01186380 about?

NCT01186380 is a clinical study titled "Safety of the PET-512MC Transesophageal Transducer". The objective of this Study is to demonstrate the safety of the PET-512MC TEE transducer as it is inserted and transitioned into the esophagus through the mouth.

What is the current status of trial NCT01186380?

This trial is currently completed. The enrollment target is 50 participants. The study started on 2010-08. Estimated completion is 2010-11.

What interventions are being tested in trial NCT01186380?

The interventions under investigation include: PET-512MC (DEVICE).

Who is sponsoring clinical trial NCT01186380?

This trial is sponsored by Toshiba America Medical Systems, which has 3 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00200889 · 50 participants · Early Phase 1

    Mapping Auricular Vagus Nerve Circuitry

  • NCT00409435 · 50 participants · Phase 2

    A Study of Pyridostigmine in Postural Tachycardia Syndrome

  • NCT01202305 · 50 participants

    The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies

  • NCT01225913 · 50 participants · Phase 4

    Mechanism(s) of Airflow Limitation During Exacerbation of Asthma

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01186380, the US trial registry maintained by the National Library of Medicine. NCT01186380 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.